Wealth Architects’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$547K Sell
1,090
-26
-2% -$12.5K 0.04% 137
2026
Q1
$548K Sell
1,116
-11
-1% -$5.97K 0.05% 134
2025
Q4
$653K Sell
1,127
-75
-6% -$42.4K 0.06% 128
2025
Q3
$583K Sell
1,202
-8
-0.7% -$3.72K 0.06% 131
2025
Q2
$491K Sell
1,210
-189
-14% -$79K 0.05% 138
2025
Q1
$696K Buy
1,399
+159
+13% +$86.1K 0.08% 115
2024
Q4
$645K Sell
1,240
-106
-8% -$58.3K 0.07% 105
2024
Q3
$832K Sell
1,346
-12
-0.9% -$7.1K 0.09% 91
2024
Q2
$751K Sell
1,358
-312
-19% -$179K 0.09% 96
2024
Q1
$971K Sell
1,670
-66
-4% -$37K 0.13% 77
2023
Q4
$921K Sell
1,736
-83
-5% -$40.2K 0.13% 76
2023
Q3
$921K Buy
1,819
+16
+0.9% +$8.53K 0.16% 71
2023
Q2
$941K Sell
1,803
-24
-1% -$13K 0.16% 70
2023
Q1
$1.05M Sell
1,827
-1
-0.1% -$564 0.19% 63
2022
Q4
$1.01M Sell
1,828
-54
-3% -$28.6K 0.19% 61
2022
Q3
$955K Buy
1,882
+139
+8% +$77.8K 0.2% 52
2022
Q2
$947K Buy
1,743
+1
+0.1% +$550 0.19% 59
2022
Q1
$1.03M Sell
1,742
-68
-4% -$39.1K 0.17% 58
2021
Q4
$1.21M Buy
1,810
+226
+14% +$141K 0.21% 50
2021
Q3
$905K Buy
1,584
+2
+0.1% +$1.1K 0.18% 59
2021
Q2
$798K Buy
1,582
+125
+9% +$59K 0.16% 62
2021
Q1
$665K Buy
1,457
+29
+2% +$13.8K 0.14% 65
2020
Q4
$665K Sell
1,428
-70
-5% -$32.8K 0.15% 60
2020
Q3
$661K Sell
1,498
-32
-2% -$13.2K 0.18% 54
2020
Q2
$554K Buy
1,530
+20
+1% +$6.7K 0.16% 64
2020
Q1
$428K Sell
1,510
-13
-0.9% -$4.1K 0.15% 70
2019
Q4
$495K Buy
1,523
+45
+3% +$13.6K 0.14% 64
2019
Q3
$430K Sell
1,478
-93
-6% -$26.6K 0.13% 68
2019
Q2
$461K Buy
1,571
+59
+4% +$16.3K 0.14% 64
2019
Q1
$414K Buy
1,512
+153
+11% +$38.1K 0.13% 68
2018
Q4
$304K Sell
1,359
-5
-0.4% -$1.17K 0.11% 87
2018
Q3
$333K Sell
1,364
-13
-0.9% -$2.99K 0.1% 91
2018
Q2
$285K Hold
1,377
0.09% 94
2018
Q1
$284K Hold
1,377
0.09% 94
2017
Q4
$261K Sell
1,377
-428
-24% -$82K 0.09% 105
2017
Q3
$342K Hold
1,805
0.12% 86
2017
Q2
$314K Hold
1,805
0.12% 87
2017
Q1
$277K Hold
1,805
0.11% 90
2016
Q4
$255K Hold
1,805
0.11% 96
2016
Q3
$287K Hold
1,805
0.13% 86
2016
Q2
$266K Sell
1,805
-17
-0.9% -$2.51K 0.13% 91
2016
Q1
$258K Sell
1,822
-4
-0.2% -$536 0.13% 92
2015
Q4
$259K Hold
1,826
0.13% 97
2015
Q3
$223K Buy
1,826
+23
+1% +$3K 0.12% 105
2015
Q2
$234K Buy
+1,803
New +$235K 0.13% 106

Other funds holding TMO

Wealth Architects's TMO Position: Q2 2026 in Review

Wealth Architects reduced its Thermo Fisher Scientific (TMO) stake by 2.3% in Q2 2026, selling an estimated $12.5K and leaving 1,090 shares worth $547K. The position accounts for 0.04% of the portfolio, ranked #137.

Wealth Architects first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $1.21M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wealth Architects held 1,090 shares of Thermo Fisher Scientific worth $547K as of Q2 2026.
  • Wealth Architects sold 26 Thermo Fisher Scientific shares in Q2 2026, an estimated $12.5K.
  • Thermo Fisher Scientific made up 0.04% of Wealth Architects's portfolio in Q2 2026, its #137 holding.
  • Wealth Architects first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
  • Wealth Architects's Thermo Fisher Scientific position peaked at $1.21M in Q4 2021.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wealth Architects's 13F filing for Q2 2026, filed 23 Jul 2026.